ÐÓ°ÉÂÛ̳

Skip to main content

Stay ahead of cervical cancer with comprehensive screening

For more than 50 years, we¡¯ve been committed to providing diagnostic insights that can help you and your patients work together for better health. You can count on Quest for co-testing solutions that give you a more complete picture:

  • Age-based Smart Codes make it easy to order cervical cancer screening based on ACOG guidelines and STI screening as appropriate
  • Liquid-based Pap tests can detect abnormal cells on the cervix
  • Aptima? HPV mRNA testing detects the presence and activity of infection
  • Co-testing with Pap and HPV together offers superior detection of risk versus either test alone1


This information is provided for informational purposes only and is not intended as medical advice. A physician¡¯s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

?

References

  1. Kaufman HW, Alagia DP, Chen Z, et al. Contributions of liquid- ?? based (Papanicolaou) cytology and human papillomavirus testing in co-testing for detection of cervical cancer and precancer in the United States. Am J Clin Pathol. 2020;154(4):510-516. doi:10.1093/ajcp/aqaa074